APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
September 6th, 2023
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
August 29th, 2023
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
August 10th, 2023
APDN to Report FQ3’23 Financial Results; Investor Conference Call/Webcast 8/10
August 7th, 2023
APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
July 18th, 2023
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
July 13th, 2023
APDN to Present at Upcoming Healthcare Investor Conference
June 8th, 2023
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
May 11th, 2023
